Broad Range of Patients with Renal Cell Carcinoma Benefit from Sutent® - Cancer Consultants Print
Cancer ConsultantsResearchers from the UK have reported that Sutent® (sunitinib) is safe and effective for a broad population of patients with metastatic renal cell carcinoma ...The Angiogenesis Inhibitor Drug Class Will Capture 87 Percent of

... read more